Appearing to stick closely to what was shown on teleprompters to the left and right of the podium with the familiar ...

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...

CEO Andrew Witty promised that UnitedHealthcare would work to speed up turnaround times for approval of some procedures and ...

In 2024, UnitedHealth Group saw full year revenue grow 8% over 2023 to reach $400.3 billion. Adjusted earnings from ...

A South Korean study explored the link between lifestyle decisions beginning in infancy and persistent atopic dermatitis, ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

Ozempic, Rybelsus and Wegovy top the list of the newest drugs selected for Medicare Part price negotiation, part of the ...

But many existing models fall short of adhering to established best practices for economic evaluation, the review authors ...

Berge will serve in this role through the end of 2026, marking another milestone in her successful career in healthcare.

More than half (53%) of patients reached remission after one year of Omvoh treatment and 46% experienced healing of the ...

Five-year survival rates improved greatly because of immunotherapy and other advances, according to the American Cancer ...